Evidence map›Paper›PMID 40794449›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2025

Genetic and Clinical Characterization of a Large Cohort with Suspected Monogenic Stone Disease.

Andrea G Cogal, Ahmed E Ali, Muhammad G Arnous, Abdulmueti Alhadi, Le-Ting Zhou, Jennifer Arroyo, Barbara M Seide, Kalina J Rossler, Laura M Reynolds, Gabrielle N Kennedy and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. The Role of Altered Mineral Metabolism in Kidney Stone Disease: Is Vitamin D the Key?American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Article
  2. The effects of elevated phosphate on the kidney - damaging the gatekeeper.Pflugers Archiv : European journal of physiology · 2026
    Review
  3. The Significance of Fibroblast Growth Factor 23 and 24,25-Dihydroxyvitamin D in Dent Disease Type 1.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
  4. From Heterogeneity to Precision in Urinary Stone Disease: Who to Test, When, and with What.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Andrea G CogalDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0002-6212-567
Ahmed E AliDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-0388-3174
Muhammad G ArnousDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-4666-4537
Abdulmueti AlhadiDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-6335-1057
Le-Ting ZhouDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-9421-8059
Jennifer ArroyoDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-8271-7184
Barbara M SeideDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0008-1536-0582
Kalina J RosslerDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-0353-1774
Laura M ReynoldsDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-9288-9964
Gabrielle N KennedyDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0002-4810-0089
Doaa E ElbarougyDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0000-6487-8312
David S GoldfarbNephrology Division, New York University Langone Health and New York University School of Medicine, New York, New York.ORCID 0000-0002-9215-1273
Dawn S MillinerDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-4799-1668
David J SasDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-4869-434
John C LieskeDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-0202-5944
Peter C HarrisDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-5304-6593
Investigators of the Rare Kidney Stone Consortium

Funding

Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)K12DK133995 · NIDDK · STANFORD UNIVERSITY · PI LINDA A DIMEGLIO, David Matthew Maahs · 2022 to 2026
$16.0M
Primary HyperoxaluriaU54DK083908 · NIDDK · MAYO CLINIC ROCHESTER · PI MILLINER, DAWN SCHMAUTZ · 2009 to 2018
$12.3M
An individualized medicine approach to urinary stone diseaseR01DK133171 · NIDDK · MAYO CLINIC ROCHESTER · PI Peter C. Harris, Felix Knauf · 2022 to 2026
$3.0M
Facilitating personalized medicine of monogenic stone patients by genetic characterizationR21TR003174 · NCATS · MAYO CLINIC ROCHESTER · PI HARRIS, PETER C., LIESKE, JOHN C · 2020 to 2021
$437k
NCATS NIH HHS R21 TR003174NCATS NIH HHS R21TR003174NIDDK NIH HHS K12 DK133995NIDDK NIH HHS R01 DK133171NIDDK NIH HHS R01DK133171NIDDK NIH HHS U54 DK083908Rare Kidney Stone Consortium U54DK83908
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CKDgenetics and development

Identifiers

PMID40794449
PMCPMC12590417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.